Surgical Management ofBRCA1andBRCA2Carriers: Bitter Choices Slightly Sweetened
- 1 November 2005
- journal article
- editorial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 23 (31), 7772-7774
- https://doi.org/10.1200/jco.2005.07.906
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Effect of Short-Term Hormone Replacement Therapy on Breast Cancer Risk Reduction After Bilateral Prophylactic Oophorectomy in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study GroupJournal of Clinical Oncology, 2005
- The use of preventive measures among healthy women who carry a BRCA1 or BRCA2 mutationFamilial Cancer, 2005
- Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategyNature, 2005
- Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymeraseNature, 2005
- The Role of BRCA1 in the Cellular Response to ChemotherapyJNCI Journal of the National Cancer Institute, 2004
- Bilateral Prophylactic Mastectomy Reduces Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study GroupJournal of Clinical Oncology, 2004
- Cancer Incidence in BRCA1 Mutation CarriersJNCI Journal of the National Cancer Institute, 2002
- Risk of Endometrial Carcinoma Associated with BRCA MutationGynecologic Oncology, 2001
- Is Uterine Papillary Serous Adenocarcinoma a Manifestation of the Hereditary Breast–Ovarian Cancer Syndrome?Gynecologic Oncology, 2000
- Is Uterine Serous Papillary Carcinoma a BRCA1-Related Disease? Case Report and Review of the LiteratureGynecologic Oncology, 1999